Spatiotemporal modeling of radiopharmaceutical transport in solid tumors: Application to 177 Lu-PSMA therapy of prostate cancer
Anahita Piranfar,M. Soltani,Farshad M. Kashkooli,Carlos F. Uribe,Arman Rahmim
DOI: https://doi.org/10.1016/j.cmpb.2023.108004
IF: 6.1
2024-01-13
Computer Methods and Programs in Biomedicine
Abstract:Background and objective 177 Lu-labeled prostate-specific membrane antigen (PSMA) radiopharmaceutical therapy (RPT) represents a pivotal advancement in addressing prostate cancer. However, existing therapies, while promising, remain incompletely understood and optimized. Computational models offer potential insights into RPTs, aiding in clinical drug delivery enhancement. In this study, we investigate the impact of various physiological parameters on the delivery of 177 Lu-PSMA-617 RPT using the convection-diffusion-reaction (CDR) model. Methods Our investigation encompasses tumor geometry and surrounding tissue, characterized by well-defined boundaries and initial conditions. Utilizing the finite element method, we solve governing equations across a range of parameters: dissociation constant K D (1, 0.1, 0.01 [nM]), internalization rate (0.01–0.0001 [min −1 ]), diverse tumor shapes, and variable necrotic zone sizes. This model can provide an accurate analysis of radiopharmaceutical delivery from the injection site to the tumor cell, including drug transport in the vascular, interstitial, and intracellular spaces, and considering important parameters (e.g., drug extravasation from microvessels or to lymphatic vessels, the extracellular matrix, receptors, and intracellular space). Results Our findings reveal significant enhancements in tumor-absorbed doses as K D decreases. This outcome can be attributed to the higher affinity of radiopharmaceuticals for PSMA receptors as K D diminishes, facilitating a more efficient binding and retention of the therapeutic agent within the tumor microenvironment. Additionally, tumor-absorbed doses for K D ∼ 1 [nM] show an upward trend with higher internalization rates. This observation can be rationalized by considering that a greater internalization rate would result in a higher proportion of radiopharmaceuticals being taken up by tumor cells after binding to receptors on the cell surface. Notably, tumor shape and necrotic zone size exhibit limited influence on tumor absorbed dose. Conclusions The present study employs the CDR model to explore the role of physiological parameters in shaping 177 Lu-PSMA-617 RPT delivery. These findings provide insights for improving prostate cancer therapy by understanding radiopharmaceutical transport dynamics. This computational approach contributes to advancing our understanding of radiopharmaceutical delivery mechanisms and has implications for enhancing treatment efficacy.
engineering, biomedical,computer science, interdisciplinary applications,medical informatics, theory & methods